NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
17.82
-1.04 (-5.51%)
At close: Mar 31, 2025, 4:00 PM
18.00
+0.18 (1.01%)
After-hours: Mar 31, 2025, 4:56 PM EDT
NovoCure Revenue
In the year 2024, NovoCure had annual revenue of $605.22M with 18.82% growth. NovoCure had revenue of $161.27M in the quarter ending December 31, 2024, with 20.54% growth.
Revenue (ttm)
$605.22M
Revenue Growth
+18.82%
P/S Ratio
3.18
Revenue / Employee
$406,734
Employees
1,488
Market Cap
1.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 605.22M | 95.88M | 18.82% |
| Dec 31, 2023 | 509.34M | -28.50M | -5.30% |
| Dec 31, 2022 | 537.84M | 2.81M | 0.53% |
| Dec 31, 2021 | 535.03M | 40.66M | 8.23% |
| Dec 31, 2020 | 494.37M | 143.05M | 40.72% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
NVCR News
- 27 days ago - Novocure to Participate in Leerink Partners 2025 Global Healthcare Conference - Business Wire
- 4 weeks ago - NovoCure Q4 2024 Earnings: Strong And Growing Pipeline - Seeking Alpha
- 4 weeks ago - NovoCure's Expansion Strategy Struggles To Translate Approvals Into Growth - Seeking Alpha
- 4 weeks ago - NovoCure Limited (NVCR) Q4 2024 Earnings Conference Call Transcript - Seeking Alpha
- 4 weeks ago - Novocure Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update - Business Wire
- 2 months ago - Novocure Inaugurates New Global Headquarters in Canton of Zug, Switzerland - Business Wire
- 2 months ago - Novocure Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company Update - Business Wire
- 3 months ago - Novocure to Participate in 43rd Annual J.P. Morgan Healthcare Conference - Business Wire